NCT05767489

Brief Summary

This is an observational study, conducted on subjects with neurological disorders primarily involving the frontal and parietal lobes of the brain. Throughout the indicated period, the study will aim to enroll 100 subjects divided into 30 units per year. Specifically, the study will be carried out on patients with fronto-parietal dysfunction for whom a prescribed a clinical investigation of electroencephalogram and MRI

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2021

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

March 2, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 14, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2024

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2025

Completed
Last Updated

March 25, 2024

Status Verified

March 1, 2023

Enrollment Period

3 years

First QC Date

March 2, 2023

Last Update Submit

March 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Combination of EEG and functional MR (fMRI)

    Interception of differences during simultaneous acquisition related to the variation of action readiness (action readiness) suggested by the visual-perceptual context

    1-36 months

Interventions

High-resolution 3D T1 and T2 sequences, acquired in the sagittal plane and MR reconstructed in the remaining orthogonal planes, for morphological assessment of different cortical and subcortical. EEG tracing involving recording channels such as eye tracking (eye-tracking: electrooculogram, pupillometry, saccades, fixation times on areas predefined areas), performance measures (response times), electrocardiogram and electromyogram proper to clinical acquisition

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects with brain dysfunction, particularly affecting the lobe frontal, temporal and parietal

You may qualify if:

  • subjects of either sex with fronto-parietal dysfunction, who are able to able to provide voluntary consent, who have been asked for clinical purposes for an EEG and an MRI

You may not qualify if:

  • pregnant or presumed pregnant subjects and subjects with claustrophobia or with contraindications to the examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Synlab SDN

Naples, 80143, Italy

RECRUITING

MeSH Terms

Interventions

Magnetic Resonance Spectroscopy

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2023

First Posted

March 14, 2023

Study Start

January 18, 2021

Primary Completion

January 31, 2024

Study Completion

January 17, 2025

Last Updated

March 25, 2024

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations